Biotech

All Articles

' Scientific intuitiveness' led FDA consultants to back Zevra's unusual illness med

.Zevra Therapeutics' unusual illness medicine appears to be on the course to approval this loss afte...

Pfizer takes $230M reached after axing stopped working DMD genetics treatment

.Pfizer's stage 3 Duchenne muscular dystrophy (DMD) gene treatment breakdown has blown a $230 thousa...

AC Immune sees 'landmark' prospective in Alzheimer's medicine data

.After more than twenty years of service neurodegenerative health conditions, Swiss biotech air cond...

GSK loses ph. 2 HPV vaccine over lack of best-in-class prospective

.GSK has ditched a period 2 individual papillomavirus (HPV) vaccination coming from its pipeline aft...

OS Therapies refiles $6M IPO to finance HER2 drug, preclinical ADCs

.Operating system Therapies will definitely list on the NYSE American stock swap this morning by mea...

ALX's waning CD47 action cost sends sell spiraling down

.ALX Oncology's period 2 stomach cancer reaction price has weakened. After observing its CD47 blocke...

Ionis centers eye disease from targets of Roche-partnered prospect after records disappoint

.Yet Another of Ionis Pharmaceuticals' vital midphase readouts has actually fallen short of expectat...

Biogen's CEO said no risky sell 2023. He prepares to be bold

.While Biogen's pharma peers are looking for late-stage properties with little danger, CEO Chris Vie...

Instil refills pipeline in $2B biobucks handle ImmunOnco

.Instil Biography has been actually a biotech in search of a pipeline after it junked its lead posse...

Biogen leaves Denali Alzheimer's collab

.Biogen has returned legal rights to a very early Alzheimer's condition program to Denali Rehabs, le...